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Abstract
Background: The lack of robust systems for monitoring quality in healthcare has been highlighted.
Statistical process control (SPC) methods, utilizing the increasingly available routinely collected
electronic patient records, could be used in creating surveillance systems that could lead to rapid
detection of periods of deteriorating standards. We aimed to develop and test a CUmulative SUM
(CUSUM) based surveillance system that could be used in continuous monitoring of clinical
outcomes, using routinely collected data. The low Apgar score (5 minute Apgar score < 7) was
used as an example outcome.
Method: A surveillance system based on the Observed minus Expected (O-E) as well as the 2-
sided Log-Likelihood CUSUM charts was developed. The Log-Likelihood chart was designed to
detect a 50% rise (deterioration) and halving (improvement) in the odds of low Apgar scores.
Baseline rates were calculated from data for 2001 to 2004, and were used to monitor deliveries
for 2005. Deliveries for nulliparous and multiparous women were monitored separately. All
analyses were retrospective.
Results: The CUSUM system detected periods of increased rates of low Apgar scores for each of
the nulliparous and multiparous cohorts. The overall rate for 2005 was eventually found to be
0.67%, which was higher than the baseline reference rate of 0.44% from 2001 to 2004.
Conclusion: CUSUM methods can be used in continuous monitoring of clinical outcomes using
routinely collected data. Used prospectively, they could lead to the prompt detection of periods of
suboptimal standards.
Background
Calls for robust systems for monitoring healthcare out-
comes have been made [1]. The increasing use of elec-
tronic patient records in healthcare presents an
opportunity for the development and application of real-
time monitoring systems that can lead to the rapid detec-
tion of adverse trends in healthcare. Statistical process
control (SPC) methods, developed and long used in qual-
ity control systems in the manufacturing industry [2],
could become central to such efforts. We describe the
design and retrospective application of a surveillance sys-
tem in the continuous monitoring of clinical outcomes
using an SPC tool known as the CUmulative SUM
(CUSUM) chart, using routinely collected data. We used a
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neonatal clinical outcome, the low Apgar score (5 minute
Apgar score < 7), as an example outcome.
The CUmulative SUM (CUSUM) chart
The CUSUM chart method, first described by Page in
1954[3], is based on sequential monitoring of a cumula-
tive performance measure over time. With several devel-
opments and adaptations, it has emerged as a suitable
method for monitoring healthcare outcomes [4-8]. We
selected and used the "Observed minus Expected" (O-E)
and the Log-likelihood CUSUM chart methods in design-
ing our surveillance tool.
Observed – Expected (O-E) CUSUM chart
This form of the CUSUM chart is a graphical representa-
tion of a running total of the difference between the
number of observed adverse events and that expected
according to a specified baseline reference rate. It is math-
ematically defined as:
Ct = Ct-1 + (Xt - X0),
where Xt is the outcome measurement for subject t
(Observed), and X0 is the baseline reference rate
(Expected), hence O – E. In binary outcome measures, Xt
equals 0 for a successful or desired outcome, and 1 for an
adverse outcome. The chart is a plot of the cumulative
sum, Ct, against t. Desired outcomes result in downward
steps, and upward steps are produced when adverse out-
comes are encountered. When the outcome rate is consist-
ent with the baseline reference rate, the plot runs
randomly about the horizontal line at zero. Although in
its simple form, the O – E chart has no limits and therefore
does not give a signal if and when the rate changes have
become statistically significant, it serves to illustrate an
overall general trend in the rates of the adverse outcome
monitored.
The Log Likelihood CUSUM chart
The Log Likelihood CUSUM chart is a probability testing
procedure that sequentially assesses whether the observed
adverse outcome rate is consistent with a specified base-
line reference rate. Each subject is given a weight Wt,
which is obtained as follows [7];
where Pt is the baseline reference rate for subject t. ORA is
a pre-specified odds ratio under the alternative hypothe-
ses.
If desired, a two-sided CUSUM chart can be designed,
where the upward chart is designed to detect an increase
in the adverse outcome rate (ORA > 1), while the down-
ward chart is designed to detect a reduction in the adverse
outcome rate (ORA < 1). In the upward chart,  is plot-
ted against t, where . The down-
ward CUSUM plots  against t, where
. These CUSUM charts are thus
restricted to always stay above or below zero, respectively.
Limits are determined and placed, with the CUSUM chart
considered to signal when such a limit is crossed. The "sig-
nal" is an indication of sufficient evidence that the adverse
outcome rate is no longer consistent with the baseline
level. When this happens, the monitoring process is
stopped to allow for appropriate previously agreed action
to be taken. This response begins with checking and con-
firming the accuracy of the data before further investiga-
tions and subsequent changes are introduced. After this,
monitoring is continued, either with the settings
unchanged or with changes made as appropriate.
Limits have an inter dependence with the Average Run
Length (ARL). The out-of control average run length (OC-
ARL) is the average number of subjects required before the
CUSUM chart signals when the level of performance is
unacceptable, and the in-control average run length (IC-
ARL) is the average number of consecutive subjects
required for the CUSUM chart to signal despite the true
rate being at an acceptable level.
The clinical outcome: The low Apgar score
We selected a typical neonatal clinical outcome, the low
Apgar score (5 minute Apgar score < 7), as an example
outcome. The Apgar score is a convenient shorthand for
reporting the status of newborn babies as well as the effect
of resuscitation[9]. It is a zero to ten (0 – 10) aggregate
score based on 5 parameters assessed in nearly all babies
born in UK hospitals as well as the rest of the world. The
low Apgar score (5 minute Apgar score < 7), has been
identified as a "key outcome" to be used in assessing the
role and impact of Electronic Fetal Monitoring (EFM)
guideline [10], produced by the National Institute for
Clinical Excellence (NICE). The Royal College of Obstetri-
cians and Gynaecologists (RCOG) have also included it in
a "trigger list" of outcomes to be monitored using the
adverse incident reporting system [11]. It is also one of the
components of the Adverse Outcome Index (AOI), a ten
outcome system recently proposed for use in the assess-
ment of quality of care in delivery units in the US [12].
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Southmead Hospital, a District General Hospital (DGH)
in Bristol with around 5000 deliveries a year, reported a
50% reduction in the rate of low Apgar scores in a subset
of term (>37 weeks gestation) deliveries, following the
introduction of regular training of all labour ward staff in
the management of obstetric emergencies[13]. Their low
Apgar score rate, which had been 0.86% in the 1998 to
1999 period, decreased to 0.44% after the introduction of
the training programme in 2000. With new standards
achieved, Southmead Hospital's data were ideal for test-
ing a surveillance system that could be used in prospective
monitoring of such clinical outcome in maternity units in
the UK. Such a system would provide early warnings when
rates of adverse outcomes are seen to be rising.
Methods
Approval for the project was obtained from Southmead
Hospital local research ethics committee. All analyses
were carried out using STATA software version 8.0 (Stata-
Corp, Texas, USA). Data were obtained from the Stork
maternity information system used at this hospital, with
the data from 2001 to 2004 used to derive baseline refer-
ence rates which were used in designing systems for mon-
itoring deliveries in 2005. We included term (>37 weeks
gestation), singleton, cephalic presenting live deliveries,
and excluded all elective caesarean sections and home
deliveries: the same inclusion and exclusion criteria used
by Draycott et al[13].
Although the data analyses were all carried out retrospec-
tively, a prospective scenario was created by serially
inspecting the data taking into account the date and time
of birth. Whenever a signal occurred, the process was
stopped to allow for appropriate evaluation. In prospec-
tive monitoring, this would trigger an investigation into
the cause of the signal, followed by appropriate corrective
action. The next phase of monitoring would then follow.
Reference rates (baseline standards)
The overall rate of low Apgar scores for 2001 to 2004 was
found to be 0.44% (Table 1), the same as that published
by Draycott et al[13]. An attempt to derive adjusted esti-
mates of the risk of low Apgar from these data, using logis-
tic regression found only "parity status" to be statistically
significant. The final model obtained was however of a
poor fit (R2 = 0.009), and was not used. Stratified analyses
were then carried out for the two groups, the nulliparous
and the multiparous women. The baseline risks of low
Apgar scores for these separate groups were 0.60% for nul-
liparous and 0.29% for multiparous women (Table 1).
The CUSUM charts were then applied to the respective
2005 deliveries data separately.
CUSUM Chart settings
Two-sided Log-Likelihood CUSUM charts were used, with
the upward chart designed to detect a 50% increase (ORA
= 1.5) and the downward charts designed to detect halv-
ing (ORA = 0.5) of the odds of low Apgar scores. Determi-
nation of the unacceptable outcome rates, and hence the
value of ORA for the Upward CUSUM as well as the limits
took into account the results presented by Draycott et al,
where the rates of low Apgar scores decreased from 0.86%
to 0.44%[13]. This new overall rate of 0.44% (1 in 227)
was regarded as the desired baseline rate which we wished
to maintain, or indeed improve on. For the 2001 to 2004
data, we found the separate corresponding rates to be
0.29% (1 in 334) and 0.60% (1 in 167) for the multipa-
rous and nulliparous women respectively. These, as well
as the predicted rates under alternative hypotheses are
illustrated in Table 1.
The CUSUM charts limits were placed at +1 and -1. A sim-
ulation approach was used to evaluate the in-control and
out-of-control ARLs for these settings. The relevant ARLs
are presented in Table 2, with corresponding values for
limits at +1.5 and -1.5 also shown for comparison.
Where necessary, conversions between the odds and prob-
ability (risks) of low Apgar were made using the following
formulae;
Odds low Apgar = p/(1 - p)
Probability of low Apgar under HA = ORApt/(1 - pt + ORApt)
Results
Out of a total of 18581 deliveries in 2001 to 2004, 15055
(81.02%) met the inclusion criteria and were used in the
generation of baseline reference rates of low Apgar scores.
There were 5010 deliveries in 2005, and 4028 (80.40%)
of them were included and were thus monitored.
Table 1: Estimates of the probability (risk) of low Apgar under the null and alternative hypotheses
Risk of low Apgar under H0:
(OR = 1)
Risk of low Apgar under HA:
(p given ORA = 0.5)
Risk of low Apgar under HA:
(p given ORA = 1.5)
Nulliparous 0.0060 (0.60%) 0.0030 (0.30%) 0.0089 (0.89%)
Multiparous 0.0029 (0.29%) 0.0015 (0.15%) 0.0044 (0.44%)
Overall 0.0044 (0.44%) 0.0022 (0.22%) 0.0066 (0.66%)
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Nulliparous women
The O – E CUSUM chart (Figure 1) shows that the rate of
low Apgar scores for nulliparous women was generally
higher in 2005 than in 2001 to 2004. Two upward
CUSUM signals were observed at the 755th and 1387th
deliveries (Figure 2). Table 3 shows a summary of results
from the different phases of monitoring for nulliparous
women. The rates of low Apgar scores during the two peri-
ods leading to signals were 0.93% and 0.95%, respec-
tively. The overall low Apgar scores rate for nulliparous
deliveries for the whole of 2005 was 0.81%.
Multiparous women
The O – E CUSUM chart for multiparous women (Figure
3) shows that the rate of low Apgar scores was generally
higher in 2005 than in 2001 to 2004. There were two sig-
nals at the 393rd and the 811th deliveries (Figure 4), with
respective low Apgar score rates of 1.02% and 0.96% at
each period. Table 4 summarises results from monitoring
multiparous deliveries. The low Apgar scores rate for mul-
tiparous women for the whole of 2005 was 0.53%.
Discussion
We have shown that a CUSUM based surveillance system
can be used in monitoring healthcare outcomes, using
routinely collected data. The O – E CUSUM chart pro-
vided a visual representation of the general trends in rates,
while the Log-likelihood CUSUM chart provided ongoing
formal statistical evaluations after each delivery, compar-
ing the "current" rate with the baseline standard (refer-
ence) rate. Upward signals were observed, and the low
Apgar score rates were confirmed to have risen signifi-
cantly above expected rates. If such a system had been in
prospective use at the time, detection of these periods
could have been an opportunity for remedial action,
potentially preventing some of the subsequent cases that
were observed. Overall, there were 27 cases of low Apgar
scores observed during the year, ten more than the
number that would be expected from standard baseline
rate of 0.44%.
The occurrence of a signal does not necessarily imply dete-
rioration in performance. A signal indicates a change in
the outcome rate, the cause of which can only be deter-
mined through subsequent investigations. All investiga-
tions should begin with checking the data for accuracy
before taking any further steps, and for the results to be
reliable the data need to be accurate. The quality of rou-
tinely collected data in the NHS has been found to vary
Log-likelihood ratio charts for nulliparous deliveries; Signals at Baby Numbers 755 nd 1387Fi ure 2
Log-likelihood ratio charts for nulliparous deliveries; Signals 
at Baby Numbers 755 and 1387.
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Table 2: Log Likelihood CUSUM chart performance – limits and corresponding ARLs
p0 p1 h IC-ARLU IC-ARLD Combined 
IC-ARL
OC-ARLU OC-ARLD Combined 
OC-ARL
Nulliparous 0.0060 0.0090 1.0 1730 1030 650 710 550 310
Multiparous 0.0029 0.0043 1.0 3500 2080 1300 1460 1140 640
Nulliparous 0.0060 0.0090 1.5 4420 2250 1490 1300 980 560
Multiparous 0.0029 0.0043 1.5 9390 5240 3360 2710 2005 1150
O – E chart for nulliparous deliveriesFigure 1
O – E chart for nulliparous deliveries.
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from place to place. Data contained in one of the mater-
nity information systems used in the UK has been shown
to be of high quality [14,15], in direct contrast to data
from other specialties [16]. Efforts at improving the qual-
ity of data should therefore be prioritised if the benefits of
methods such as the CUSUM are to be realised.
The CUSUM technique has several methodological char-
acteristics that should make it perform better than the
commonly used healthcare quality control tools such as
incident reporting and clinical audit, or indeed any other
methods that report aggregate results. Unlike adverse inci-
dent reporting which has been shown to be incomplete
and insensitive [17,18], the complete inspection of all rel-
evant data ensures that no cases are missed. The retention
of memory of recent results allows the CUSUM to detect
even the small persistent shifts in rates which are other-
wise easily missed. Unlike aggregate methods where poor
runs can be compensated for and hidden by the existence
of excellent results from elsewhere, the serial and contin-
uous nature of data inspection allows the CUSUM to
detect both good and bad runs separately as they occur,
providing an opportunity for corrective action.
In common with all statistical tests, the CUSUM tech-
nique is associated with false positive and false negative
states. A false positive is when the CUSUM gives an alarm
when in actual fact performance is at an acceptable level
and the rate of the poor outcomes has not changed. A false
negative state exists when no alarms occur in the presence
of suboptimal performance. The choice and placement of
chart limits determines which of the two states is more
likely to occur, and reducing the likelihood of one
increases that of the other. This is connected to the deter-
mination of the ARL, with an ideal CUSUM design being
one where the OC-ARL is short, and the IC-ARL is suffi-
ciently long. In monitoring healthcare outcomes, a more
sensitive system, i.e. one with shorter OC-ARL is to be pre-
ferred. In our situation, the low frequency of adverse out-
comes as well as the small absolute differences between
the desired and the undesirable rates places greater
emphasis on greater sensitivity (hence lower limits).
Higher limits could easily allow a return to the previous
rates without this change being detected. In summary, for
the nulliparous deliveries, there would be a signal after an
average of 1730 deliveries, even if the rate of low Apgar
Log-likelihood ratio chart for multiparous deliveries; Signals at Baby Numbers 393 nd 811Fi ure 4
Log-likelihood ratio chart for multiparous deliveries; Signals 
at Baby Numbers 393 and 811.
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Table 3: Nulliparous deliveries: Details of alarms and action taken
Alarm details Conclusion and Action
Phase 1:
1 – 755
Upward alarm at 755th delivery
Rate: 7 in 755 (0.93%)
Increase in rate of low Apgar scores
Look for cause and take corrective action
Continue monitoring (p0 = 0.0060, h+ = 1)
Phase 2:
756 – 1387
Upward alarm at 1387th delivery
Rate: 6 in 632 (0.95%)
Increase in rate of low Apgar scores
Look for cause and take corrective
Continue monitoring (p0 = 0.0060, h+ = 1)
Phase 3:
1388 – end
No alarms
Rate: 3 in 579 (0.52%)
Continue monitoring (p0 = 0.0060, h+ = 1)
O – E chart for multiparous deliveriesFigure 3
O – E chart for multiparous deliveries.
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scores had not increased (Table 2). For multiparous deliv-
eries, the corresponding value is 3500. Corresponding
ARL values for limits at +1.5 and -1.5 are also shown for
comparison.
Case-mix adjustment
Adjustment for case-mix is an important development to
be added to the CUSUM methodology, and should ideally
be used. Care is however required as risk-adjustment can
be associated with a number of problems. Firstly, poorly
fitting models may result from issues such as the absence
of data on an important confounder. Secondly, the shelf
life of even the best fitting models may be limited due to
the dynamism of healthcare, where groups previously
found to be at high risk of a certain outcome can quickly
change to a different level of risk due to changes in prac-
tice.
In our study, a poorly fitting risk adjusted model was
obtained and has not been used. Given the low event rate
of our outcome, the large uncertainty in the model predic-
tions could overshadow the changes in the rate of low
Apgar scores. Adjustment through stratification of sub-
jects into more homogeneous groups (nulliparous and
multiparous) was considered an appropriate alternative
option and was used here. Stratification, however, has its
own disadvantages. The number of subjects in the groups
being monitored is reduced and as a result, the power to
detect small changes with any certainty, especially with a
low event rate, is reduced. Increasing the number of
groups that have to be simultaneously monitored results
in increased risks of false signals due to problems of mul-
tiple testing[19]. In our case, a large number of deliveries
were available and they were stratified to only two groups.
Conclusion
A CUSUM based surveillance system can be used in con-
tinuous monitoring of clinical outcomes such as the low
Apgar score, using the readily available "routinely col-
lected data". This system could allow hospitals opportuni-
ties to improve standards of care for the patients in their
care. Further research in a prospective setting is however
required in order to fully evaluate these tools. Such evalu-
ations should address the practicalities of using such sys-
tems as well as their clinical and cost effectiveness before
wider uptake is advised.
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